Last reviewed · How we verify
NCT05949398
Evaluation of the Prevalence of Oral HPV Infection in Patients Who Are Positive to the PAP-test
trial in HPV Infection in 50 participants. Status unknown.
13 September 2023
Quick facts
| Lead sponsor | University of Catania |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 March 2021 |
| Primary completion | 13 September 2023 |
| Estimated completion | 26 September 2023 |
| Sites | 1 location across Italy |
Conditions studied
- HPV Infection — all drugs for HPV Infection →
Sponsor
University of Catania
Who can join
Adults 18 to 80, female only, with HPV Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present cross-sectional study aims to assess the prevalence and type distribution of oral HPV infection in PAP-test-positive women aged ≥18 years. The means used in the present study will be the use of anamnestic questionnaires and exfoliative cytology tests at predetermined oral mucosal sites (lingual belly and dorsum, palate, and buccal mucosa).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05949398
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HPV Infection
Currently open trials in the same condition.
- NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
- NCT07281677 — Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years · Phase 4 · recruiting
- NCT06507917 — Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for · NA · recruiting
- NCT07336134 — PopSci CHW4CervixHealth · NA · recruiting
- NCT06959563 — Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV · EARLY_PHASE1 · active not recruiting
Other University of Catania trials
Trials by the same sponsor.
- NCT07455643 — Closed-loop Response to Unannounced Mixed and Carbohydrates-rich Breakfasts · NA · completed
- NCT06831487 — Analysis of Line-Field Confocal Optical Coherence Tomography (LC-OCT) in Characterization of Gingival Systemic Health, G · NA · enrolling by invitation
- NCT06725095 — Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis · NA · enrolling by invitation
- NCT06020937 — Olfactory and Trigeminal Functions in Patients With Multiple Sclerosis: Case-control Study · not yet recruiting
- NCT07300657 — Impact of an AI-Based Chatbot on Implant Patient Management: RCT · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05949398 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Catania
- Last refreshed: 18 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05949398.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing